Glaucoma Surgery Market, 2012-2023

January 2018 | 189 pages | ID: G765A22512AEN
Precision Business Insights (PBI)

Abstracts

Glaucoma Surgery Market: Glaucoma disease causes due to increase in intraocular pressure within the eye that damages the optic nerve and leads to loss of vision and even blindness. Glaucoma is second leading cause of irreversible blindness in the world. The most common types of glaucoma are open angle glaucoma and closed angle glaucoma. The common symptoms associated with glaucoma include eye pain, blurred vision, red eyes, light appears to extra halo-like glow around it, and vision problems with poor lighting. Glaucoma can be diagnosed by determining the intraocular pressure, the status of optic nerve and drainage angle, and visual fields. Glaucoma can be treated by using eye drops, laser treatments, and surgery.The global glaucoma surgery market is expected to grow at a significant CAGR due to increase in the geriatric population as they are more prone to eye diseases.

Glaucoma Surgery Market Outline

Rise in prevalence of glaucoma, new developments in minimally invasive glaucoma surgical devices, and increase in prevalence of diabetes and diabetic retinopathy expected to fuel the glaucoma surgery market over the forecast period. Furthermore, changing lifestyle, unhealthy food, increase in incidence of ocular disorders, improved medical coverage, and increase in healthcare expenditure expected to bolster the global glaucoma surgery market. However, lack of awareness among key stakeholders about eye disorders, dearth of skilled professionals for glaucoma surgeries, stringent regulatory policies, and high cost of glaucoma surgery might hamper the growth of global glaucoma surgery market over the forecast period.

The glaucoma surgery market is segmented on the basis of disease type, surgery type, and end user

Based on surgery type, glaucoma surgery market has been segmented into the following:

• Trabeculoplasty
• Filtering surgery (viscocanalostomy)
• Drainage implant (aqueous shunt implant)
• Iridotomy
• Others

Based on disease type, glaucoma surgery market has been segmented into the following:

• Open-angle glaucoma
• Closed-angle glaucoma
• Low-tension glaucoma
• Pigmentary glaucoma
• Others

Based on end-user, glaucoma surgery market has been segmented into the following:

• Hospitals
• Ophthalmology Clinics
• Ambulatory surgical centers

Market players are adopting different strategies to increase their market share in the glaucoma surgery market. Acquisitions & mergers, collaborations, technological developments such as inserting implants by minimally invasive surgical procedures, and organizing training programs for physicians regarding glaucoma surgeries expected to bolster the global glaucoma surgery market. For instance, in September 2016, Johnson & Johnson acquired Abbott Medical Optics business segments that include laser refractive surgery, cataract surgery, and consumer eye health. In December 2016, Ellex Medical Lasers conducted clinical training for physicians about operation of Ellex iTrack minimally invasive glaucoma surgery device in China. Moreover, approval of new products from various administrative bodies also propel the glaucoma surgery market growth. For instance, in March 2016, Glaukos Corporation announced that the company’s trabecular micro-bypass stent named iStent was approved in Japan by Japanese Ministry of Health, Labor and Welfare (MHLW). In August 2016, Alcon received FDA approval for the CyPass a micro-invasive surgical device to treat open-angle glaucoma. In the near future, pipeline products that can treat glaucoma are expected to create significant opportunities for the device manufacturers.

Geographically, the global glaucoma surgery market segmented into the following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share followed by Europe and Asia-Pacific. North America holds dominant share in glaucoma surgery market which is mainly attributed to the availability of skilled professionals, increase in the incidence of glaucoma patients (according to Glaucoma Research Foundation survey, approximately one out of 10,000 babies born with glaucoma in United States), and increase in healthcare expenditure. Europe market is growing at significant CAGR owing to increase in the prevalence of glaucoma disease. In Europe, Italy has the highest prevalence for glaucoma disease that is approximately 182 prevalent cases per 100,000 population. Austria, Spain, and Germany also play a key role in Europe glaucoma surgery market due to the increase in prevalence cases. Asia-Pacific holds a key share due to increase in the geriatric population, rise in the prevalence of glaucoma disease patients majorly in India, China, and Japan.

Some of the players in glaucoma surgery market are Glaukos Corporation (U.S.), Ellex Medical Lasers (Australia), DOSE Medical Corporation (U.S.), Johnson & Johnson Services Inc., (U.S.), Abbott Laboratories (U.S.), and Alcon (Novartis) (U.S.) to name a few.

In April 2017, Glaukos Corporation acquired intraocular pressure sensor system from DOSE Medical to develop and commercialize breakthrough products and procedures to treat glaucoma

In April 2017, Alcon launched Cypass micro stent, glaucoma surgical device with micro invasiveness to treat open-angle glaucoma

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL GLAUCOMA SURGERY MARKET INTRODUCTION

2.1. Global Glaucoma Surgery Market – Taxonomy
2.2. Global Glaucoma Surgery Market –Definitions
  2.2.1. Surgery Type
  2.2.2. Disease Type
  2.2.3. End-User

3. GLOBAL GLAUCOMA SURGERY MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Glaucoma Surgery Market Dynamics – Factors Impact Analysis
3.6. Global Glaucoma Surgery Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe
  3.6.3. Japan

4. GLOBAL GLAUCOMA SURGERY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL GLAUCOMA SURGERY MARKET, BY SURGERY TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Trabeculoplasty
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Filtering surgery (viscocanalostomy)
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Drainage implant (aqueous shunt implant)
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Iridotomy
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Others
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis

6. GLOBAL GLAUCOMA SURGERY MARKET FORECAST, BY DISEASE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Open-angle glaucoma
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Closed-angle glaucoma
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Low-tension glaucoma
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Pigmentary glaucoma
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL GLAUCOMA SURGERY MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Hospitals
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Ophthalmology Clinics
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Ambulatory surgical centers
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL GLAUCOMA SURGERY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. North America
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Glaucoma Surgery Market - Opportunity Analysis Index, By Surgery Type, By Disease Type, By End-User, and Region, 2017 – 2023

9. NORTH AMERICA GLAUCOMA SURGERY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Surgery Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Trabeculoplasty
  9.1.2. Filtering surgery (viscocanalostomy)
  9.1.3. Drainage implant (aqueous shunt implant)
  9.1.4. Iridotomy
  9.1.5. Others
9.2. Disease Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Open-angle glaucoma
  9.2.2. Closed-angle glaucoma
  9.2.3. Low-tension glaucoma
  9.2.4. Pigmentary glaucoma
  9.2.5. Others
9.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Hospitals
  9.3.2. Ophthalmology Clinics
  9.3.3. Ambulatory surgical centers
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
9.5. North America Glaucoma Surgery Market - Opportunity Analysis Index, By Surgery Type, By Disease, By End-User, and Country, 2017 – 2023
9.6. North America Glaucoma Surgery Market Dynamics – Trends

10. EUROPE GLAUCOMA SURGERY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Surgery Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Trabeculoplasty
  10.1.2. Filtering surgery (viscocanalostomy)
  10.1.3. Drainage implant (aqueous shunt implant)
  10.1.4. Iridotomy
  10.1.5. Others
10.2. Disease Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Open-angle glaucoma
  10.2.2. Closed-angle glaucoma
  10.2.3. Low-tension glaucoma
  10.2.4. Pigmentary glaucoma
  10.2.5. Others
10.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Hospitals
  10.3.2. Ophthalmology Clinics
  10.3.3. Ambulatory surgical centers
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Germany
  10.4.2. UK
  10.4.3. France
  10.4.4. Spain
  10.4.5. Italy
  10.4.6. Russia
  10.4.7. Poland
  10.4.8. Rest of Europe
10.5. Europe Glaucoma Surgery Market - Opportunity Analysis Index, By Surgery Type, By Disease, By End-User and Country, 2017 – 2023
10.6. Europe Glaucoma Surgery Market Dynamics – Trends

11. ASIA-PACIFIC GLAUCOMA SURGERY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Surgery Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Trabeculoplasty
  11.1.2. Filtering surgery (viscocanalostomy)
  11.1.3. Drainage implant (aqueous shunt implant)
  11.1.4. Iridotomy
  11.1.5. Others
11.2. Disease Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Open-angle glaucoma
  11.2.2. Closed-angle glaucoma
  11.2.3. Low-tension glaucoma
  11.2.4. Pigmentary glaucoma
  11.2.5. Others
11.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Hospitals
  11.3.2. Ophthalmology Clinics
  11.3.3. Ambulatory surgical centers
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  11.4.1. Japan
  11.4.2. China
  11.4.3. India
  11.4.4. ASEAN
  11.4.5. Australia & New Zealand
  11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Glaucoma Surgery Market - Opportunity Analysis Index, By Surgery Type, By Disease, By End-User and Country, 2017 – 2023
11.6. Asia-Pacific Glaucoma Surgery Market Dynamics – Trends

12. LATIN AMERICA GLAUCOMA SURGERY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Surgery Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Trabeculoplasty
  12.1.2. Filtering surgery (viscocanalostomy)
  12.1.3. Drainage implant (aqueous shunt implant)
  12.1.4. Iridotomy
  12.1.5. Others
12.2. Disease Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. Open-angle glaucoma
  12.2.2. Closed-angle glaucoma
  12.2.3. Low-tension glaucoma
  12.2.4. Pigmentary glaucoma
  12.2.5. Others
12.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Hospitals
  12.3.2. Ophthalmology Clinics
  12.3.3. Ambulatory surgical centers
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Brazil
  12.4.2. Mexico
  12.4.3. Argentina
  12.4.4. Venezuela
  12.4.5. Rest of Latin America
12.5. Latin America Glaucoma Surgery Market - Opportunity Analysis Index, By Surgery Type, By Disease, By End-User and Country, 2017 – 2023
12.6. Latin America Glaucoma Surgery Market Dynamics – Trends

13. MIDDLE EAST AND AFRICA GLAUCOMA SURGERY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

13.1. Surgery Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Trabeculoplasty
  13.1.2. Filtering surgery (viscocanalostomy)
  13.1.3. Drainage implant (aqueous shunt implant)
  13.1.4. Iridotomy
  13.1.5. Others
13.2. Disease Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.2.1. Open-angle glaucoma
  13.2.2. Closed-angle glaucoma
  13.2.3. Low-tension glaucoma
  13.2.4. Pigmentary glaucoma
  13.2.5. Others
13.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. Hospitals
  13.3.2. Ophthalmology Clinics
  13.3.3. Ambulatory surgical centers
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.4.1. Gulf Cooperation Council (GCC) Countries
  13.4.2. Israel
  13.4.3. South Africa
  13.4.4. Rest of MEA
13.5. MEA Glaucoma Surgery Market - Opportunity Analysis Index, By Surgery Type, By Disease, By End-User and Country, 2017 – 2023
13.6. MEA Glaucoma Surgery Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Surgery Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Glaukos Corporation (U.S.)
  14.2.2. Ellex Medical Lasers (Australia)
  14.2.3. DOSE Medical Corporation (U.S.)
  14.2.4. Johnson & Johnson Services Inc., (U.S.)
  14.2.5. Abbott Laboratories (U.S.)
  14.2.6. Alcon (Novartis) (U.S.)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS